Endomag

📍 Cambridge, United Kingdom🗓 Founded 2007👥 119 employees💰 Last funded 2018
Medical Device🌐 endomag.com
Website LinkedIn
Endomag is a medical technology company devoted to improving the global standard of cancer care. Our Sentimag® probe, Magseed® marker and Magtrace® lymphatic mapping agent are already in use by many of the world’s leading physicians and cancer centres. Our goal is to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. We’ve helped tens of thousands of women around the world access more precise and less invasive breast cancer care. Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), we continue to develop our unique clinical platform from our headquarters in Cambridge, United Kingdom.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2007
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Endomag?
Endomag has 1 investors on record on gritt.io.
When did Endomag last raise funding?
The most recent investment in Endomag recorded on gritt.io was in 2018.
When was Endomag founded?
Endomag was founded in 2007.
What industry is Endomag in?
Endomag operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Endomag based?
Endomag is headquartered in Cambridge, United Kingdom.